Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-15 | 5 | 2003 | 76 | 0.620 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2014 | 388 | 0.570 |
Why?
|
| Receptors, Interleukin-2 | 6 | 2003 | 67 | 0.520 |
Why?
|
| Lymphocytes | 2 | 2002 | 470 | 0.360 |
Why?
|
| Nuclear Proteins | 3 | 2011 | 731 | 0.320 |
Why?
|
| Cysteine Endopeptidases | 4 | 2014 | 87 | 0.320 |
Why?
|
| Autoimmunity | 1 | 2010 | 172 | 0.310 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 212 | 0.300 |
Why?
|
| Intestinal Mucosa | 6 | 2014 | 809 | 0.300 |
Why?
|
| Lymphocyte Activation | 4 | 2002 | 759 | 0.250 |
Why?
|
| Tight Junctions | 3 | 2015 | 151 | 0.220 |
Why?
|
| Colitis | 3 | 2015 | 251 | 0.220 |
Why?
|
| Receptors, Interleukin-15 | 5 | 2003 | 8 | 0.210 |
Why?
|
| Homeostasis | 4 | 2003 | 429 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 2375 | 0.180 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 5 | 2014 | 15 | 0.180 |
Why?
|
| T-Lymphocytes | 5 | 2003 | 1237 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2001 | 607 | 0.170 |
Why?
|
| Signal Transduction | 6 | 2003 | 3442 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 200 | 0.160 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 237 | 0.140 |
Why?
|
| Interleukin-10 | 2 | 2015 | 157 | 0.140 |
Why?
|
| Interleukin-2 | 3 | 2002 | 240 | 0.140 |
Why?
|
| Dextran Sulfate | 2 | 2015 | 69 | 0.130 |
Why?
|
| Tight Junction Proteins | 1 | 2015 | 14 | 0.130 |
Why?
|
| Peptide Hormones | 1 | 2015 | 30 | 0.120 |
Why?
|
| Killer Cells, Natural | 3 | 2003 | 278 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 1998 | 554 | 0.120 |
Why?
|
| Mice | 12 | 2015 | 11993 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 2440 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 1998 | 743 | 0.110 |
Why?
|
| Interferon Type I | 1 | 2015 | 191 | 0.110 |
Why?
|
| Animals | 14 | 2015 | 27783 | 0.100 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2012 | 16 | 0.100 |
Why?
|
| Cell Division | 3 | 2003 | 692 | 0.100 |
Why?
|
| Colon | 1 | 2015 | 522 | 0.100 |
Why?
|
| Immunologic Memory | 2 | 2002 | 171 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2015 | 679 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 6 | 2015 | 3303 | 0.090 |
Why?
|
| Adoptive Transfer | 3 | 2015 | 170 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 101 | 0.090 |
Why?
|
| Anthrax | 1 | 2010 | 30 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 140 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2010 | 272 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2015 | 1559 | 0.080 |
Why?
|
| Bacillus anthracis | 1 | 2010 | 73 | 0.080 |
Why?
|
| Intestinal Diseases | 1 | 2010 | 79 | 0.080 |
Why?
|
| Microbiota | 1 | 2014 | 411 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2011 | 1248 | 0.080 |
Why?
|
| Transfection | 1 | 2010 | 910 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2015 | 2053 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 925 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 434 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 1183 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 765 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 977 | 0.070 |
Why?
|
| Intestines | 3 | 2010 | 419 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 829 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 1892 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1877 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 906 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2012 | 469 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 705 | 0.050 |
Why?
|
| fas Receptor | 1 | 2003 | 77 | 0.050 |
Why?
|
| Apoptosis | 3 | 2012 | 1723 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1713 | 0.050 |
Why?
|
| Interferon Inducers | 1 | 2001 | 4 | 0.050 |
Why?
|
| Poly I-C | 1 | 2001 | 19 | 0.050 |
Why?
|
| CD28 Antigens | 1 | 2002 | 89 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2001 | 173 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 54 | 0.040 |
Why?
|
| Cell Survival | 1 | 2003 | 984 | 0.040 |
Why?
|
| Cytokines | 2 | 2015 | 817 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2000 | 81 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2020 | 36 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 231 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 308 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2001 | 2891 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 179 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 296 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 1589 | 0.040 |
Why?
|
| Humans | 6 | 2020 | 91073 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 2506 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 437 | 0.030 |
Why?
|
| Piroxicam | 1 | 2015 | 11 | 0.030 |
Why?
|
| Models, Biological | 1 | 2002 | 1771 | 0.030 |
Why?
|
| Protective Agents | 1 | 2015 | 34 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 138 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2033 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 22 | 0.030 |
Why?
|
| Proteins | 1 | 2000 | 800 | 0.030 |
Why?
|
| Cell Movement | 1 | 1998 | 793 | 0.030 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2014 | 15 | 0.030 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2014 | 24 | 0.030 |
Why?
|
| Inflammation | 1 | 2000 | 998 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 278 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 86 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 243 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2014 | 345 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 342 | 0.030 |
Why?
|
| Actins | 1 | 2015 | 468 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 158 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1500 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 2416 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2615 | 0.020 |
Why?
|
| Female | 3 | 2015 | 47186 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 429 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3716 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1806 | 0.020 |
Why?
|
| Male | 2 | 2015 | 43249 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6847 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2003 | 23 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 58 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2003 | 67 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 2003 | 38 | 0.010 |
Why?
|
| Thymectomy | 1 | 2003 | 31 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 309 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 433 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2000 | 42 | 0.010 |
Why?
|
| Cachexia | 1 | 2000 | 13 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2000 | 58 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2000 | 72 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2000 | 74 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2000 | 1131 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2000 | 766 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 19574 | 0.010 |
Why?
|
| Skin | 1 | 2000 | 586 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 605 | 0.010 |
Why?
|
| Liver | 1 | 2000 | 1222 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 26555 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 27147 | 0.010 |
Why?
|
| Kidney | 1 | 2000 | 1153 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 1313 | 0.010 |
Why?
|